Infusion Therapy Market Size, Share, Trends, Growth and Forecast 2034

Infusion Therapy Industry Perspective:

The global infusion therapy market size was worth around USD 49.58 billion in 2024 and is predicted to grow to around USD 83.10 billion by 2034 with a compound annual growth rate (CAGR) of roughly 5.30% between 2025 and 2034.

Request Free Sample

Key Insights:

• As per the analysis shared by our research analyst, the global infusion therapy market is estimated to grow annually at a CAGR of around 5.30% over the forecast period (2025-2034)
• In terms of revenue, the global infusion therapy market size was valued at around USD 49.58 billion in 2024 and is projected to reach USD 83.10 billion, by 2034.
• The market is projected to grow at a significant rate due to the growing number of patients worldwide requiring drip therapy.
• Based on the type, the infusion pump segment is growing at a high rate and will continue to dominate the global market as per industry projections.
• Based on the application, the antibiotic/antiviral therapy segment is anticipated to command the largest market share.
• Based on region, North America is projected to dominate the global market during the forecast period.

Infusion Therapy Market: Overview

Infusion therapy refers to the administration of medicinal drugs or fluids using a catheter or a needle. It is a method of drug delivery for medicines that cannot be consumed orally. Additionally, infusion therapy is also used for administering drugs that must be dispensed in controlled dosages. In most cases, the intravenous (IV) method of infusion therapy is used for drug administration. However, some of the other methods deployed in the infusion therapy industry include subcutaneous, intramuscular, and epidural therapies. Certain medications cannot be consumed orally since the drugs can lose their effectiveness when exposed to the digestive system. Infusion therapy, in such cases, is an efficient alternative to ensuring optimal drug delivery.

In addition to this, infusion therapies can also be used in circumstances where the patient is unable to consume medicines orally such as senior citizens. An emerging application of infusion therapy has been reported in the form of delivering nutrition to the body directly using several methods available in the market.

During the forecast period, demand for infusion therapy is expected to witness high growth due to the rising number of patients with cancer and other conditions requiring drip therapy for drug administration. The industry may face challenges due to several health risks associated with infusion therapies such as the risk of allergy and collapsed veins.

Infusion Therapy Market: Growth Drivers

Growing number of patients worldwide requiring drip therapy to fuel market expansion

The global infusion therapy market is expected to be driven by the rising number of patients requiring infusion therapy. Intravenous method of drug delivery is widely used during the chemotherapy process for a large number of cancer types. Drugs delivered during chemotherapy must be administered in controlled dosage and slowly. Ensuring optimal drug delivery during chemotherapy can be achieved by using infusion therapy. Furthermore, the method allows the drugs to directly reach a patient's bloodstream improving the medicine's overall efficacy. Infusion therapy is sometimes used for injecting drugs into the spine or other specific body parts of a patient.

In addition to this, infusion therapy has also shown applications in treating other common conditions such as lupus, rheumatoid arthritis, ulcerative colitis, Crohn’s disease, and psoriatic arthritis. The increasing number of patients worldwide suffering from cancer and other chronic conditions such as diabetes will facilitate increased demand and application of modern infusion therapies.

Rising expansion in the home care segment will accelerate market expansion in the coming years

Increasing demand for remote patient care and personalized medical assistance has created new growth avenues for providers of infusion therapies. Healthcare givers deliver infusion therapy-based services at the patient's home which facilitates higher comfort for the individual receiving the treatment. Increasing initiatives undertaken by regional governments and private companies to incorporate and improve output related to at-home medical care will facilitate increased revenue for the global infusion therapy market players in the coming years.

For instance, Section 5012 of the 21st Century Cures Act in the US provides a new Medicare benefit to patients seeking home infusion therapy-associated professional services for specific types of biologics and drugs.

Infusion Therapy Market: Restraints

Health risks associated with IV drips to limit market expansion in the future

The global infusion therapy industry is expected to be restricted by the growing concerns over risks associated with the therapies. For instance, infusion methods in healthcare are minimally invasive procedures. They can cause discomfort among patients due to excessive use of catheters and needles.

Furthermore, the process of inserting needles can be challenging in patients with small veins. Some of the common risks associated with infusion therapies include air embolism, infection, collapsed veins, and phlebitis. Infusion reactions such as headache, cough, nausea, and fever among others can also be observed in patients receiving the treatment.

Infusion Therapy Market: Opportunities

Growing launch of new infusion devices and therapies to generate growth opportunities for the players

The global infusion therapy market is projected to generate growth opportunities due to the rising launch of new and modern infusion devices. For instance, increasing investments in integrating Internet of Things (IoT) connected and Artificial Intelligence (AI)-powered infusion administering or monitoring devices may aid higher growth momentum in the industry.

In April 2025, ICU Medical, a leading medical technology company from the US, announced that it had received US Food & Drugs Administration (FDA) 510(k) approval for new products in its infusion pump portfolio. The agency has cleared the use of the Plum Solo precision IV pump along with the updated versions of LifeShield infusion safety software and the Plum Duo pump. The products aim to reduce and eliminate infusion consistencies often associated with traditionally used pumps.

In February 2025, Supernus Pharmaceuticals, Inc. received approval from the FDA for ONAPGO (apomorphine hydrochloride) injection. It is the first and only subcutaneous apomorphine infusion device used in treating motor fluctuations in adults suffering from Parkinson’s disease (PD). The product is expected to be made available in the second quarter of 2025 according to reports.

Infusion Therapy Market: Challenges

Lack of standard insurance coverage and mounting waste to challenge market growth trends

The global infusion therapy industry is projected to be challenged by the lack of standard insurance coverage policies for IV therapies. Additionally, medical waste generated from the growing use of infusion devices has become a major cause of concern among market players and environmental agencies. These factors will affect smooth growth in the industry during the forecast period.

Infusion Therapy Market: Report Scope

Infusion Therapy Market: Segmentation

The global infusion therapy market is segmented based on type, application, and region.

Based on the type, the global market segments are needleless connectors, infusion pumps, intravenous sets, intravenous solutions, and IV cannulas. In 2024, the highest growth was listed in the infusion pumps segment holding prominence over 50% of the total revenue. Infusion pumps are the most commonly used infusion devices, especially with growing applications in chemotherapy. During the forecast period, it will continue to dominate the market trends according to research.

Based on the application, the global market divisions are pain management, hydration therapy, chemotherapy, parenteral nutrition, antibiotic/antiviral therapy, diabetes, and others. In 2024, the highest revenue was generated by the antibiotic/antiviral therapy segment accounting for nearly 31% of the total share. The growing number of patients requiring antiviral or antibiotic infusions worldwide is propelling segmental revenue. During the forecast period, parenteral nutrition will emerge as the fastest-growing segment due to the rising number of end-users.

Infusion Therapy Market: Regional Analysis

North America to deliver the highest revenue during the forecast period

The global infusion therapy market is expected to be led by North America during the forecast period. In 2024, the region accounted for nearly 37% of the global revenue with the US taking the lead in the regional industry. The presence of a robust and highly effective healthcare system in North America helps the region thrive. In recent times, FDA approvals for modern infusion therapy devices have increased further propelling the regional market revenue. Europe is a significant market for infusion therapy. The rising number of elderly populations, higher access to quality medical care, and comprehensive medical coverage policies for the regional population will aid higher growth in Europe.

Asia-Pacific is a growing market with countries such as India, China, South Korea, and Japan generating significant revenue for the region. The growing number of accidents in the region that are known to restrict a patient’s ability to consume oral drugs may propel the demand for drip therapies in the coming years. Additionally, rising advancements in infusion therapies, growing construction of cancer-care facilities, and a surge in overall healthcare investments will push growth horizons for the Asia-Pacific market.

Infusion Therapy Market: Competitive Analysis

The global infusion therapy market is led by players like:

• Terumo Corporation
• Baxter International Inc.
• Fresenius Kabi AG
• Option Care Health Inc.
• Amgen Inc.
• B. Braun Melsungen AG
• Coram CVS Specialty Infusion Services
• Smiths Medical
• Eli Lilly and Company
• BD (Becton
• Dickinson and Company)
• Nipro Corporation
• ICU Medical Inc.
• InfuSystem Holdings Inc.
• CareCentrix Inc.
• Pfizer Inc.

The global infusion therapy market is segmented as follows:

By Type

• Needleless Connectors
• Infusion Pumps
• Intravenous Sets
• Intravenous Solutions
• IV Cannulas

By Application

• Pain Management
• Hydration Therapy
• Chemotherapy
• Parenteral Nutrition
• Antibiotic/Antiviral Therapy
• Diabetes
• others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa